ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 280

The Fascia Is a Target Organ of Inflammation in Autoimmune Diseases

Kentaro Noda, Ken Yoshida, Taro Ukichi, Kazuhiro Furuya, Kenichiro Hirai, Isamu Kingetsu and Daitaro Kurosaka, Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: autoimmune diseases, dermatomyositis, myositis and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Muscle Biology, Myositis and Myopathies Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: We previously reported that inflammation
occurred early in the fascia of patients with dermatomyositis. We often
encounter patients with autoimmune diseases who present with muscle symptoms, such
as pain and weakness and biopsies of the affected muscle areas do not show
inflammatory cell infiltration among the muscle fibers, thereby leaving the
cause of these symptoms unclear. To date, the work-up for autoimmune disease
patients presenting with muscle symptoms has focused on the presence or absence
of muscle fiber inflammation, and not on the presence or absence of fasciitis.
Therefore,we thoroughly investigated the lesions of fasciae and muscles in
patients with muscle symptoms and elevated muscle enzyme levels.

Methods: This study included patients with autoimmune diseases who
presented with myalgia, muscle weakness, or elevated serum levels of muscle
enzymes (CK and aldolase), and were admitted to the Division of Rheumatology of
Jikei University School of Medicine Hospital between April 2007 and December
2013. They underwent magnetic resonance imaging (MRI) and en bloc
biopsy.

Results: Sixty-three patients presented with myalgia, muscle
weakness, and elevated levels of muscle enzymes (CK and aldolase), and
consisted of 26 with dermatomyositis (DM), 19 with polymyositis (PM), 9 with
clinically amyopathic dermatomyositis (CADM), 7 with systemic lupus
erythematosus (SLE), and 2 with adult-onset Still’s disease (AOSD). MRI was
performed in all sixty-three patients. Fascia involvement was observed in 45
(71.43%) of patients : in 23 (88.46%) out of 26 with DM, 7 (36.84%) out of 19
with PM, 6 (66.67%) out of 9 with CADM, all 7 with SLE, and all 2 with AOSD. Histopathological
examination was performed in thirty-five patients. Fasciitis was observed in 23
(65.71%) of patients�Fin 15 (83.33%) out of 18 with DM, 2 (25%) out of 8 with PM, 3 (50%)
out of 6 with CADM, and 3 (100%) out of 3 with SLE. Many patients with
fasciitis also had myalgia. However, myositis was not associated with myalgia.
Muscle weakness was not associated with fasciitis. A high percentage of
patients with normal serum CK levels and elevated serum aldolase levels,
developed fasciitis.

Conclusion: Fasciitis occurred in patients with various autoimmune
diseases. Patients with myalgia may have fasciitis in autoimmune diseases.


Disclosure: K. Noda, None; K. Yoshida, None; T. Ukichi, None; K. Furuya, None; K. Hirai, None; I. Kingetsu, None; D. Kurosaka, None.

To cite this abstract in AMA style:

Noda K, Yoshida K, Ukichi T, Furuya K, Hirai K, Kingetsu I, Kurosaka D. The Fascia Is a Target Organ of Inflammation in Autoimmune Diseases [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-fascia-is-a-target-organ-of-inflammation-in-autoimmune-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-fascia-is-a-target-organ-of-inflammation-in-autoimmune-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology